8-K: Nu-Med Plus Schedules Annual Meeting, Amends Bylaws

Nu-Med Plus, Inc. announced its 2026 Annual Meeting date and updated its bylaws regarding jurisdiction transfers.

Summary

• Nu-Med Plus, Inc. has scheduled its 2026 Annual Meeting of Shareholders for December 14, 2026, to be held virtually.
• Shareholders of record as of November 6, 2026, are eligible to vote.
• The company's Board of Directors amended the bylaws on November 2, 2026, to require a majority shareholder vote for any transfer of the company's domicile or domestication to a jurisdiction outside of Utah.
• Deadlines for shareholder proposals and director nominations for the annual meeting are set for November 13, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily focused on procedural updates and the scheduling of an annual meeting, with no significant financial or strategic revelations.

Positives

• Clear scheduling of the 2026 Annual Meeting provides shareholders with a definitive date.
• Bylaw amendment clarifies the process and shareholder approval required for domicile changes, enhancing corporate governance transparency.

Negatives

• No new financial performance data or strategic initiatives were disclosed in this filing.

Risks

• Shareholder proposals or director nominations submitted after the November 13, 2026 deadline will be considered untimely.
• The company reserves the right to change the date and record date for the Annual Meeting, creating potential uncertainty for shareholders.

Future Outlook

The filing does not contain specific forward-looking financial guidance. The primary forward-looking information pertains to the scheduling of the 2026 Annual Meeting and the process for shareholder submissions.

Management Comments

• The company reserves the right to change the date of the Annual Meeting prior thereto.
• The Company, however, reserves the right to change the record date prior to the Annual Meeting.
• Any shareholder proposal intended to be considered for inclusion in the Companys proxy materials for the Annual Meeting in accordance with Rule 14a-8 or pursuant to the Companys Bylaws, must be delivered to, or mailed to and received at, the Companys principal executive offices at 640 Belle Terre Rd., Building 2 E, Port Jefferson, NY 11777, Attention: Corporate Secretary, on or before the close of business on November 13 2026, which date the Company has determined to be a reasonable time before it expects to begin to print and distribute its proxy materials prior to the Annual Meeting.
• Additionally, any shareholder who intends to submit a director nomination or who intends to submit a proposal regarding any other matter of business at the Annual Meeting other than in accordance with Rule 14a-8 or otherwise must similarly make sure that such nomination or proposal is delivered to, or mailed and received at, the Companys principal executive offices on or before the close of business on November 13, 2026.

Industry Context

StockSavvy.ai notes that amendments to bylaws concerning domicile transfers are common for companies incorporated in states with specific corporate laws, like Utah, as they navigate potential future strategic decisions or regulatory environments. The scheduling of annual meetings is a standard corporate governance practice.

Corporate Governance

Stakeholder Impact

• Shareholders: Will have a defined date for the annual meeting and a clear process for submitting proposals and nominations. Their voting rights on domicile changes are reinforced.
• Management: Must adhere to the new bylaw requirements for any future domicile change considerations.
• Creditors/Suppliers: No direct impact indicated by this filing.

Next Steps

• The company will file its definitive proxy statement for the Annual Meeting.
• Shareholders will submit proposals or director nominations by November 13, 2026.
• The 2026 Annual Meeting of Shareholders will be held virtually on December 14, 2026.

Key Dates

Keywords

Annual Meeting, Bylaws Amendment, Shareholder Proposals, Director Nominations, Corporate Governance, Domestication, Jurisdiction Transfer